4//SEC Filing
Macdonald R. Loch 4
Accession 0001127602-18-012504
CIK 0001472091other
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 4:03 PM ET
Size
5.0 KB
Accession
0001127602-18-012504
Insider Transaction Report
Form 4
Macdonald R. Loch
DirectorChief Scientific Officer
Transactions
- Sale
Common Stock
2018-03-22$16.41/sh−2,500$41,025→ 570,602 total
Footnotes (2)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $16.25 to $16.56 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Edge Therapeutics, Inc.
CIK 0001472091
Entity typeother
Related Parties
1- filerCIK 0001653008
Filing Metadata
- Form type
- 4
- Filed
- Mar 21, 8:00 PM ET
- Accepted
- Mar 22, 4:03 PM ET
- Size
- 5.0 KB